Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M. Mathis, Wenxuan Ye, Addison J. Hu et al.|Nature Communications|2024Cited by 57
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M. Mathis, Wenxuan Ye, Alexander E. Webber et al.|medRxiv|2023Cited by 7
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6Michael Schoof, Corie Y. Ralston, Bryan Faust et al.|Unknown|2020Cited by 0
Structure of anti-SARS-CoV-2 Spike nanobody mNb6Michael Schoof, Corie Y. Ralston, Bryan Faust et al.|Unknown|2020Cited by 0